111 related articles for article (PubMed ID: 24403235)
1. Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behavior.
Morin E; Cheng S; Mete O; Serra S; Araujo PB; Temple S; Cleary S; Gallinger S; Greig PD; McGilvray I; Wei A; Asa SL; Ezzat S
Cancer Med; 2013 Oct; 2(5):701-11. PubMed ID: 24403235
[TBL] [Abstract][Full Text] [Related]
2. Belzutifan for von Hippel-Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study.
Else T; Jonasch E; Iliopoulos O; Beckermann KE; Narayan V; Maughan BL; Oudard S; Maranchie JK; Iversen AB; Goldberg CM; Fu W; Perini RF; Liu Y; Linehan WM; Srinivasan R
Clin Cancer Res; 2024 May; 30(9):1750-1757. PubMed ID: 38393723
[TBL] [Abstract][Full Text] [Related]
3. Characteristics, Treatment, Outcomes, and Survival in Neuroendocrine G1 and G2 Pancreatic Tumors: Experiences From a Single Tertiary Referral Center.
Calissendorff J; Bjellerup-Calissendorff F; Bränström R; Juhlin CC; Falhammar H
Front Endocrinol (Lausanne); 2021; 12():657698. PubMed ID: 33927695
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery.
Spolverato G; Bagante F; Aldrighetti L; Poultsides G; Bauer TW; Field RC; Marques HP; Weiss M; Maithel SK; Pawlik TM
J Gastrointest Surg; 2017 Dec; 21(12):2039-2047. PubMed ID: 28744737
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Tumor Prognosis of Pancreatic Neuroendocrine Tumors Using Image, Surgical and Pathologic Findings.
Chen F; Huang Y; Chen C; Zhang Y; Zhang Y; Wan R; Xu M
Neuro Endocrinol Lett; 2023 Oct; 44(7):453-464. PubMed ID: 37874552
[TBL] [Abstract][Full Text] [Related]
6. Prognostic differences in grading and metastatic lymph node pattern in patients with small bowel neuroendocrine tumors.
Reinhard L; Mogl MT; Benz F; Dukaczewska A; Butz F; Dobrindt EM; Tacke F; Pratschke J; Goretzki PE; Jann H
Langenbecks Arch Surg; 2023 Jun; 408(1):237. PubMed ID: 37332044
[TBL] [Abstract][Full Text] [Related]
7. Analysis of 6,747 pancreatic neuroendocrine tumors for a proposed staging system.
Martin RC; Kooby DA; Weber SM; Merchant NB; Parikh AA; Cho CS; Ahmad SA; Kim HJ; Hawkins W; Scoggins CR
J Gastrointest Surg; 2011 Jan; 15(1):175-83. PubMed ID: 21103949
[TBL] [Abstract][Full Text] [Related]
8. Ki-67 index and response to chemotherapy in patients with neuroendocrine tumours.
Childs A; Kirkwood A; Edeline J; Luong TV; Watkins J; Lamarca A; Alrifai D; Nsiah-Sarbeng P; Gillmore R; Mayer A; Thirlwell C; Sarker D; Valle JW; Meyer T
Endocr Relat Cancer; 2016 Jul; 23(7):563-70. PubMed ID: 27412968
[TBL] [Abstract][Full Text] [Related]
9. p21 Protein Outperforms Clinico-pathological Criteria in Predicting Liver Metastases in Pancreatic Endocrine Tumors.
Nasir A; Ahmed MK; Saller JJ; Henderson-Jackson EB; Malafa MP; Yeatman TJ; Coppola D
Cancer Genomics Proteomics; 2023; 20(6):522-530. PubMed ID: 37889062
[TBL] [Abstract][Full Text] [Related]
10. Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors.
Scott AT; Weitz M; Breheny PJ; Ear PH; Darbro B; Brown BJ; Braun TA; Li G; Umesalma S; Kaemmer CA; Maharjan CK; Quelle DE; Bellizzi AM; Chandrasekharan C; Dillon JS; O'Dorisio TM; Howe JR
Clin Cancer Res; 2020 Apr; 26(8):2011-2021. PubMed ID: 31937620
[TBL] [Abstract][Full Text] [Related]
11. A Systematic Review of Proinsulin-Secreting Pancreatic Neuroendocrine Tumors.
Murtha TD; Lupsa BC; Majumdar S; Jain D; Salem RR
J Gastrointest Surg; 2017 Aug; 21(8):1335-1341. PubMed ID: 28510792
[TBL] [Abstract][Full Text] [Related]
12. Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control Study.
Sadot E; Reidy-Lagunes DL; Tang LH; Do RK; Gonen M; D'Angelica MI; DeMatteo RP; Kingham TP; Groot Koerkamp B; Untch BR; Brennan MF; Jarnagin WR; Allen PJ
Ann Surg Oncol; 2016 Apr; 23(4):1361-70. PubMed ID: 26597365
[TBL] [Abstract][Full Text] [Related]
13. Impact of grade on workup of rectal neuroendocrine tumors: a retrospective cohort study : Grade impact on workup of rectal NETs.
Watanabe A; Rai S; Yip L; Brown CJ; Loree JM; Stuart HC
World J Surg Oncol; 2024 Apr; 22(1):98. PubMed ID: 38627724
[TBL] [Abstract][Full Text] [Related]
14. Impact of sex on treatment decisions and outcome in patients with neuroendocrine neoplasms.
Beck J; Siebenhüner A; Wild D; Christ E; Refardt J
Endocr Relat Cancer; 2024 Mar; 31(3):. PubMed ID: 38117915
[TBL] [Abstract][Full Text] [Related]
15. Renal Neuroendocrine Tumor: A Case Report with Evaluation of Grading Criteria and Relationship with Carbonic Anhydrase 9 Immunoreactivity.
Monroe HL; Patadji Santiago S; Williams HJ; El Naili R
Int J Surg Pathol; 2024 May; 32(3):570-577. PubMed ID: 37461831
[TBL] [Abstract][Full Text] [Related]
16. Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study.
Halperin DM; Shen C; Dasari A; Xu Y; Chu Y; Zhou S; Shih YT; Yao JC
Lancet Oncol; 2017 Apr; 18(4):525-534. PubMed ID: 28238592
[TBL] [Abstract][Full Text] [Related]
17. Analyses of sex-based clinicopathological differences among patients with gastrointestinal neuroendocrine neoplasms in Europe.
Jann H; Krieg S; Krieg A; Eschrich J; Luedde T; Kostev K; Loosen S; Roderburg C
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7557-7563. PubMed ID: 36971798
[TBL] [Abstract][Full Text] [Related]
18. Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression.
Fahrmann JF; Wasylishen AR; Pieterman CRC; Irajizad E; Vykoukal J; Wu R; Dennison JB; Peterson CB; Zhao H; Do KA; Halperin DM; Agarwal SK; Blau JE; Jha S; Rivero JD; Nilubol N; Walter MF; Welch JM; Weinstein LS; Vriens MR; van Leeuwaarde RS; van Treijen MJC; Valk GD; Perrier ND; Hanash SM; Katayama H
J Clin Endocrinol Metab; 2023 Nov; 108(12):3260-3271. PubMed ID: 37307230
[TBL] [Abstract][Full Text] [Related]
19. A Phase II Trial of Ziv-Aflibercept in Patients With Advanced Pancreatic Neuroendocrine Tumors.
Halperin DM; Lee JJ; Ng CS; Strosberg JR; Estrella JS; Dagohoy CG; Dasari A; Yao JC
Pancreas; 2019 Mar; 48(3):381-386. PubMed ID: 30768575
[TBL] [Abstract][Full Text] [Related]
20. Sex-Based Clinicopathologic and Survival Differences Among Patients with Pancreatic Neuroendocrine Tumors.
Greenberg JA; Ivanov NA; Egan CE; Lee YJ; Zarnegar R; Fahey TJ; Finnerty BM; Min IM
J Gastrointest Surg; 2022 Nov; 26(11):2321-2329. PubMed ID: 35915373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
